It is predicted that between 3 and 10 in every 100 cancers are connected with inherited faulty genes.
You may be at an increased risk if one or several of your family members develop cancer.
Eiira Genetics focuses solely on detecting your hereditary cancer risk.
With a simple genetic test kit at home, you can assess the cancer risks which include breast cancer, prostate cancer, thyroid cancer, colorectal cancer, ovarian cancer, uterine cancer, kidney or renal cancer, melanoma, and gastric cancer.
What is cancer
Cancer, in essence, is an abnormal growth of cells within the body. Essentially, it starts when certain cells begin to multiply uncontrollably.
Over time, these cells form a mass known as a tumor. Consequently, if not detected and addressed early, it can potentially spread to other parts of the body, hence becoming a life-threatening condition.
Breast cancer:
About 1 in 7 women are diagnosed with breast cancer. However, early detection has a high rate of recovery.
Breast cancer tumors can be benign (non-cancerous) or malignant (cancerous).
In the case of breast cancer, the tumor is malignant, and it can invade surrounding tissues and potentially spread to other parts of the body through the bloodstream or lymphatic system.
It is advised that women check their breasts for any changes regularly and get examined by a doctor.
Genes covered by testing for hereditary breast cancer at Eiira Genetics include,
BRCA1, BRCA2, PALB2, TP53, PTEN, CDH1, STK11, NF1, ATM, CHEK2, BARD1, RAD51C, RAD51D
Ovarian cancer:
Ovarian cancer is a type of cancer that begins in the ovaries, the small organs in a woman's reproductive system responsible for producing eggs and hormones.
Women above the age of 50 are at a high risk for ovarian cancer.
The other risk factors include inheriting a gene mutation, Lynch syndrome, or a family history of ovarian cancer.
You can take a simple test and get tested for the following gene mutations assessing your ovarian cancer risk at Eiira.
BRCA1, BRCA2, PALB2, RAD51C, RAD51D, BRIP1, MLH1, MSH2, EPCAM, MSH6, PMS2
Colorectal cancer:
Colorectal cancer starts in the colon or rectum. These cancers are also called colon or rectal cancer, depending on where they start.
Colon cancer develops in your colon, the long tube that carries digested food to the rectum.
Our genetic testing profile includes testing for the following genes for colon cancer.
MLH1, MSH2, MSH6, PMS2, EPCAM, APC, MUTYH, STK11, SMAD4, BMPR1A, PTCH, PTEN
Prostate cancer:
Prostate cancer develops in the reproductive part of men, which is the prostate gland.
Prostate cancer grows very slowly.
Most of the time, the tumors are detected before they spread beyond the prostate.
You can discover your risk by testing the following prostate cancer gene mutations at Eiira.
BRCA2, HOXB13, BRCA1, MLH1, MSH2, MSH6, EPCAM, PMS2, ATM, CHEK2, PALB2, TP53
Melanoma:
Melanoma is a type of skin cancer that begins in the melanocytes, the cells responsible for the pigment in the skin.
It is the most dangerous form of skin cancer due to its ability to spread to other parts of the body.
Melanoma often appears as a mole or a dark spot on the skin, and it can develop from pre-existing moles or suddenly appear as a new lesion.
Eiira helps to test the below gene mutations, to assess your risk for melanoma.
CDKN2A, BAP1, CDK4, POT1, TERT, MITF1, MC1R, ASIP, TYR, TYRP1, TP53
Kidney/Renal cancer:
Kidney cancer, also known as renal cancer, is a type of cancer that originates in the kidneys, two bean-shaped organs responsible for filtering waste and excess fluids from the blood to produce urine.
Kidney cancer can develop in the lining of the kidney tubules or the renal pelvis.
It is one of the more common types of cancer and is detected in its early stages due to symptoms like blood in the urine, flank pain, or a palpable mass in the abdomen.
Genes that you can test for kidney and kidney cancer in Eiira Genetics are listed below.
VHL, FLCN, FH, MET, PTEN, SDHB, BAP1
Thyroid cancer:
Thyroid cancer is a relatively rare form of cancer that develops in the thyroid gland, a small butterfly-shaped organ located in the front of the neck.
Thyroid cancer typically manifests as a lump or nodule in the thyroid, and it can often be detected early due to visible or palpable abnormalities in the neck.
However, Thyroid cancer has a high survival rate, especially when diagnosed at an early stage.
You can also assess your risk of hereditary thyroid cancer at Eiira Genetics by testing the following genes.
RET, APC, PTEN, DICER1, TP53
Uterine cancer:
Uterine cancer, also known as endometrial cancer, is a type of cancer that starts in the lining of the uterus, known as the endometrium.
It is the most common cancer of the female reproductive system.
Uterine cancer is often associated with postmenopausal women, but it can affect women of all ages.
You can also opt for genetic testing to assess your risk of hereditary uterine cancer. The following genes are tested.
MLH1, MSH2, MSH6, PMS2, PTEN
Pancreatic cancer:
Pancreatic cancer is a highly aggressive and often lethal form of cancer that originates in the pancreas, a vital organ located deep within the abdomen.
The pancreas is critical in regulating blood sugar levels and aiding digestion.
Unfortunately, pancreatic cancer is often diagnosed at an advanced stage when symptoms become noticeable, which can make it challenging to treat effectively.
Testing for the following genes at Eiira will help you know your risks of hereditary pancreatic cancer.
BRCA2, ATM, PALB2, MLH1, MSH2, EPCAM, MSH6, PMS2
Gastric cancer:
Gastric cancer, commonly known as stomach cancer, is a type of malignancy that originates in the lining of the stomach.
It can develop slowly over time and often shows subtle symptoms in its early stages, making early detection challenging.
The Eiira genetic test profile includes testing for CDH1 and CTNNA1 mutations, which are associated with an increased risk of Gastric cancer.
